DXM Abuse Prevention Act of 2017 This bill amends the Federal Food, Drug, and Cosmetic Act to:
(1) require a retailer that sells certain drugs containing dextromethorphan (DXM) to have a verification system that is intended to ensure that no one under 18 years of age purchases such drugs from the retailer,
(2) establish other restrictions on the sale of over-the-counter drugs containing DXM, and
(3) establish restrictions on the distribution of bulk DXM.